|Articles|February 11, 2022
- Pharmaceutical Commerce - February 2022
- Volume 17
- Issue 1
Pharmaceutical Commerce - February 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce February 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 3 years ago
A Lowdown on Logisticsover 3 years ago
The Shifting Course in Logistics Supportover 3 years ago
How 3PLs Can Up Their Pharma Gameover 3 years ago
For Industry in Flux, is M&A Jolt in Store?over 3 years ago
CAR-T Therapies: Three Supply Chain Considerationsover 3 years ago
The Risk of Doubling Down on Pharmaover 3 years ago
Striving for Authentic, Transparent Track and Traceover 3 years ago
2022 Pharma 3PL Service Provider Directoryalmost 4 years ago
Booster Rollout Lessons for Pharmaalmost 4 years ago
Assessing Adoption of Hybrid DtP ModelsNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models
2
Cambrex Commits $120 Million to Grow US API Manufacturing
3
How Biopharma Companies Can Optimize Field Reimbursement Models
4
BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal
5
